Results 241 to 250 of about 368,709 (304)

Improved mRNA-based RSV vaccine with PreF forming enveloped virus-like particles. [PDF]

NPJ Vaccines
Chai P, Shi Y, Li X, Yang M, Liu X, Liu M, Yu J, Yin X, Li D, Li K, Kong X, Zhang Q, Wang H, Sun X, Li J, Li L, Li D, Pang L, Lu X, Duan Z.   +19 more
europepmc   +1 more source

NIR‐II Imaging‐Guided Photothermal Activation of a TRPV4‐Targeted Nanoplatform Delivering Cycloastragenol to Promote Microglia Reprogramming and α‐Synuclein Clearance in Parkinson's Disease

Advanced Science, EarlyView.
ABSTRACT Current therapies for Parkinson's disease (PD) fail to concurrently address α‐synuclein (α‐syn) aggregation and microglia‐mediated neuroinflammation. Herein, we engineer a near‐infrared‐II (NIR‐II) phototheranostic nanoplatform, CAG/FD1080@MM‐aTRPV4, for synergistic regulation of microglial function and real‐time monitoring of PD pathology. We
Hsuan Lo, Linjuan Feng, Shiying Li, Lik Hang Hugo Tse, Xuehan Wang, Xingyang Zhao, Shaoheng Ma, Xin Li, Yanjuan Gu, Wing‐Tak Wong   +9 more
wiley   +1 more source

Platform Process for an Autonomous Production of Virus-like Particles. [PDF]

ACS Omega
Baukmann S, Hengelbrock A, Katsoutas K, Stitz J, Schmidt A, Strube J.   +5 more
europepmc   +1 more source

Self-assembly and immunogenicity of virus-like particles from goose astrovirus 1 structural protein following proteolytic maturation in a baculovirus system. [PDF]

Poult Sci
Wang A, Wu Z, Liu L, Zhou Q, Cheng Y, Jia W, Lu H, Xie J, Zhu S.   +8 more
europepmc   +1 more source

Development of Methods to Produce SARS CoV-2 Virus-Like Particles at Scale. [PDF]

Biotechnol Bioeng
Edeling MA, Earnest L, Carrera Montoya J, Yap AHY, Mumford J, Roberts J, Wong CY, Hans D, Grima J, Bisset N, Bodle J, Rockman S, Torresi J.   +12 more
europepmc   +1 more source

Engineering virus-like particles for safe and versatile modeling of SARS-CoV-2 host interaction and immune escape. [PDF]

Commun Biol
Ma L, Lin Y, Ma S, Chen K, Lin Y.
europepmc   +1 more source

mRNA vaccine expressing enterovirus D68 virus-like particles induces potent neutralizing antibodies and protects against infection. [PDF]

Mol Ther Nucleic Acids
Kunishima Y, Senpuku K, Kataoka-Nakamura C, Hirai T, Yoshioka Y.   +4 more
europepmc   +1 more source

Erratum to "Dual-Stage Cross-Flow Filtration: Integrated Capture and Purification of Virus-Like Particles". [PDF]

Biotechnol Bioeng
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Hybrid Ty Virus-Like Particles

International Reviews of Immunology, 1994
Vaccines need to activate antigen presenting cells, overcome genetic restriction in T-cell responses and elicit both T and B memory cells. In order to produce recombinant vaccines which can do this, considerable effort has been put into developing particulate antigen presentation systems to generate polyvalent, high molecular weight antigens which ...
S E, Adams, N R, Burns, G T, Layton, A J, Kingsman   +3 more
openaire   +2 more sources